Kisameet Clay Isolated from the Central Coast of British Columbia, Canada, Demonstrates Broad-Spectrum Antimicrobial Activity

by George G. Zhanel, James A. Karlowsky
Published 2016-05-01

Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada

by George G. Zhanel, Michael A. Zhanel, James A. Karlowsky
Published 2018-01-01

Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile Infection

by George G Zhanel, Andrew J Walkty, James A Karlowsky
Published 2015-01-01

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli

by George G. Zhanel, Michael A. Zhanel, James A. Karlowsky
Published 2018-01-01

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections

by George G. Zhanel, Michael A. Zhanel, James A. Karlowsky
Published 2020-01-01

Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis

by George G. Zhanel, Andrew J. Walkty, James A. Karlowsky
Published 2016-01-01

Cefotaxime susceptibility should not be used to predict ceftriaxone susceptibility among Klebsiella oxytoca clinical isolates

by Andrew Walkty, Heather J. Adam, James A. Karlowsky, David C. Alexander
Published 2020-06-01

Factors Influencing Fluoroquinolone Resistance

by Daniel F. Sahm, Clyde Thornsberry, Mark E. Jones, James A. Karlowsky
Published 2003-12-01

In Vitro Activities of Ceftobiprole and Doripenem Tested against Frequently Encountered Aerobic and Facultative Gram-Positive and Gram-Negative Bacterial Pathogens Isolated from Pa...

by James A Karlowsky, Mel DeCorby, Daryl J Hoban, George G Zhanel
Published 2009-01-01

Mutant Prevention Concentrations of Doripenem and Meropenem Alone and in Combination with Colistin (Polymyxin E), Levofloxacin and Tobramycin in Pseudomonas aeruginosa

by George G Zhanel, Vibhu Vishisht, Ed Tam, Daryl J Hoban, James A Karlowsky
Published 2009-01-01

Caulobacter Species as a Cause of Postneurosurgical Bacterial Meningitis in a Pediatric Patient

by Natalie Bridger, Andrew Walkty, Maryanne Crockett, Sergio Fanella, Kim Nichol, James A Karlowsky
Published 2012-01-01

Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections – SMART United States 2018–2019

by James A. Karlowsky, Sibylle H. Lob, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Published 2021-03-01

Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19

by George G. Zhanel, Michael A. Zhanel, Kevin F. Boreskie, Joseph P. Lynch, James A. Karlowsky
Published 2021-01-01

Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015

by James A. Karlowsky, Daryl J. Hoban, Meredith A. Hackel, Sibylle H. Lob, Daniel F. Sahm
Published 2017-05-01

Antimicrobial-Resistant Streptococcus pneumoniae in Canadian Hospitals: Results from the 2007 CANWARD Study

by Aleksandra K Wierzbowski, Franil Tailor, Kim Nichol, James A Karlowsky, Daryl J Hoban, George G Zhanel
Published 2009-01-01

Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in L...

by Mark G. Wise, James A. Karlowsky, Elkin V. Lemos-Luengas, Rafael R. Valdez, Daniel F. Sahm
Published 2023-05-01

The New Fluoroquinolones: A Critical Review

by George G Zhanel, Andrew Walkty, Lavern Vercaigne, James A Karlowsky, John Embil, Alfred S Gin, Daryl J Hoban
Published 1999-01-01

In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance...

by James A. Karlowsky, Sibylle H. Lob, Krystyna M. Kazmierczak, Katherine Young, Mary R. Motyl, Daniel F. Sahm
Published 2020-06-01

Antimicrobial susceptibility testing of clinical isolates of Gram-negative bacilli collected in Morocco by the ATLAS Global Surveillance Program from 2018 to 2020

by James A. Karlowsky, Samuel K. Bouchillon, Amina Benaouda, Nabila Soraa, Khalid Zerouali, Naglaa Mohamed, Taha Alami, Daniel F. Sahm
Published 2022-09-01

Mechanisms of Reduced Susceptibility to Ciprofloxacin in Escherichia coli Isolates from Canadian Hospitals

by Patricia J Baudry-Simner, Amanpreet Singh, James A Karlowsky, Daryl J Hoban, George G Zhanel, Canadian Antimicrobial Resistance Alliance
Published 2012-01-01